Cargando…
Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways
BACKGROUND: Giant-cell arteritis (GCA) is considered a T helper (Th)1- and Th17-mediated disease. Interleukin (IL)-12 is a heterodimeric cytokine (p35/p40) involved in Th1 differentiation. When combining with p19 subunit, p40 compose IL-23, a powerful pro-inflammatory cytokine that maintains Th17 re...
Autores principales: | Espígol-Frigolé, Georgina, Planas-Rigol, Ester, Lozano, Ester, Corbera-Bellalta, Marc, Terrades-García, Nekane, Prieto-González, Sergio, García-Martínez, Ana, Hernández-Rodríguez, Jose, Grau, Josep M., Cid, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920281/ https://www.ncbi.nlm.nih.gov/pubmed/29731755 http://dx.doi.org/10.3389/fimmu.2018.00809 |
Ejemplares similares
-
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients
por: Prieto-González, Sergio, et al.
Publicado: (2017) -
Relapses in Patients With Giant Cell Arteritis: Prevalence, Characteristics, and Associated Clinical Findings in a Longitudinally Followed Cohort of 106 Patients
por: Alba, Marco A., et al.
Publicado: (2014) -
Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis—a prospective longitudinal study
por: Visvanathan, Sudha, et al.
Publicado: (2011) -
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2023) -
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis
por: Corbera-Bellalta, Marc, et al.
Publicado: (2022)